Finally, Stifel Nicolaus set a $136.00 price target on shares of Mirum Pharmaceuticals in a research report on Thursday, May 7th. Get Mirum Pharmaceuticals alerts:View Our Latest Stock Analysis on Mirum PharmaceuticalsMirum Pharmaceuticals Price PerformanceShares of MIRM opened at $105.79 on Thursday. Insider Buying and Selling at Mirum PharmaceuticalsIn other Mirum Pharmaceuticals news, SVP Jolanda Howe sold 2,721 shares of Mirum Pharmaceuticals stock in a transaction dated Wednesday, July 1st. Mirum Pharmaceuticals insider saleMirum Pharmaceuticals Company Profile(Get Free Report)Mirum Pharmaceuticals, Inc is a late-stage biopharmaceutical company dedicated to the development and commercialization of innovative therapies for rare cholestatic liver diseases. Recommended StoriesReceive News & Ratings for Mirum Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mirum Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.